Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2006 5
2007 3
2008 5
2009 10
2010 11
2011 13
2012 14
2013 7
2014 4
2015 3
2016 4
2017 13
2018 10
2019 12
2020 12
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year

Citations

18 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
Magliozzi R, Howell OW, Nicholas R, Cruciani C, Castellaro M, Romualdi C, Rossi S, Pitteri M, Benedetti MD, Gajofatto A, Pizzini FB, Montemezzi S, Rasia S, Capra R, Bertoldo A, Facchiano F, Monaco S, Reynolds R, Calabrese M. Magliozzi R, et al. Among authors: calabrese m. Ann Neurol. 2018 Apr;83(4):739-755. doi: 10.1002/ana.25197. Ann Neurol. 2018. PMID: 29518260 Free article.
OBJECTIVE: Gray matter (GM) damage and meningeal inflammation have been associated with early disease onset and a more aggressive disease course in multiple sclerosis (MS), but can these changes be identified in the patient early in the disease course? ...
OBJECTIVE: Gray matter (GM) damage and meningeal inflammation have been associated with early disease onset and a more aggressive disease co …
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group. Sinnecker T, et al. Among authors: calabrese m. JAMA Neurol. 2019 Dec 1;76(12):1446-1456. doi: 10.1001/jamaneurol.2019.2478. JAMA Neurol. 2019. PMID: 31424490 Free PMC article.
IMPORTANCE: The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies. ...
IMPORTANCE: The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
OBJECTIVE: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS). METHODS: We retrospectively collected data of PwMS with sus …
OBJECTIVE: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus …
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study.
Ferraro D, Annovazzi P, Moccia M, Lanzillo R, De Luca G, Nociti V, Fantozzi R, Paolicelli D, Ragonese P, Gajofatto A, Boffa L, Cavalla P, Lo Fermo S, Buscarinu MC, Lorefice L, Cordioli C, Calabrese M, Gallo A, Pinardi F, Tortorella C, Di Filippo M, Camera V, Maniscalco GT, Radaelli M, Buttari F, Tomassini V, Cocco E, Gasperini C, Solaro C; RIREMS (Rising Researchers in Multiple Sclerosis). Ferraro D, et al. Among authors: calabrese m. Mult Scler Relat Disord. 2020 Jan;37:101461. doi: 10.1016/j.msard.2019.101461. Epub 2019 Oct 19. Mult Scler Relat Disord. 2020. PMID: 31678859
BACKGROUND: The prevalence of trigeminal neuralgia (TN) in Multiple Sclerosis (MS) patients is higher than in the general population and its management can be particularly challenging. ...
BACKGROUND: The prevalence of trigeminal neuralgia (TN) in Multiple Sclerosis (MS) patients is higher than in the general popu …
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy.
Crescenzo F, Marastoni D, Bovo C, Calabrese M. Crescenzo F, et al. Among authors: calabrese m. Mult Scler Relat Disord. 2020 Sep;44:102372. doi: 10.1016/j.msard.2020.102372. Epub 2020 Jul 4. Mult Scler Relat Disord. 2020. PMID: 32650121 Free PMC article.
Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immunosuppressive therapy are more susceptible to developing COVID-19 or have worse outcomes. ...
Neurologists are interested in understanding whether patients with multiple sclerosis (pwMS) undergoing immunomodulatory/immun …
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.
Magliozzi R, Scalfari A, Pisani AI, Ziccardi S, Marastoni D, Pizzini FB, Bajrami A, Tamanti A, Guandalini M, Bonomi S, Rossi S, Mazziotti V, Castellaro M, Montemezzi S, Rasia S, Capra R, Pitteri M, Romualdi C, Reynolds R, Calabrese M. Magliozzi R, et al. Among authors: calabrese m. Ann Neurol. 2020 Sep;88(3):562-573. doi: 10.1002/ana.25786. Epub 2020 Jul 9. Ann Neurol. 2020. PMID: 32418239
OBJECTIVE: Intrathecal inflammation correlates with the grey matter damage since the early stages of multiple sclerosis (MS), but whether the cerebrospinal fluid (CSF) profile can help to identify patients at risk of disease activity is still unclear. ...
OBJECTIVE: Intrathecal inflammation correlates with the grey matter damage since the early stages of multiple sclerosis (MS), …
Exploring the origins of grey matter damage in multiple sclerosis.
Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Calabrese M, et al. Nat Rev Neurosci. 2015 Mar;16(3):147-58. doi: 10.1038/nrn3900. Nat Rev Neurosci. 2015. PMID: 25697158 Free article. Review.
Multiple sclerosis is characterized at the gross pathological level by the presence of widespread focal demyelinating lesions of the myelin-rich white matter. ...
Multiple sclerosis is characterized at the gross pathological level by the presence of widespread focal demyelinating lesions
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis.
Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M. Scalfari A, et al. Among authors: calabrese m. Neurology. 2018 Jun 12;90(24):e2107-e2118. doi: 10.1212/WNL.0000000000005685. Epub 2018 May 16. Neurology. 2018. PMID: 29769373 Free article.
OBJECTIVE: To investigate the relationship among cortical radiologic changes, the number of early relapses (ERs), and the long-term course of multiple sclerosis (MS). METHODS: In this cohort study, we assessed the number of cortical lesions (CLs) and white matter (W …
OBJECTIVE: To investigate the relationship among cortical radiologic changes, the number of early relapses (ERs), and the long-term course o …
Cortical Gray Matter MR Imaging in Multiple Sclerosis.
Calabrese M, Castellaro M. Calabrese M, et al. Neuroimaging Clin N Am. 2017 May;27(2):301-312. doi: 10.1016/j.nic.2016.12.009. Epub 2017 Feb 1. Neuroimaging Clin N Am. 2017. PMID: 28391788 Review.
Several neuropathologic and imaging studies have consistently confirmed that multiple sclerosis affects both white (WM) and gray matter (GM) and that GM damage plays a key role in disability progression. ...
Several neuropathologic and imaging studies have consistently confirmed that multiple sclerosis affects both white (WM) and gr …
117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page